Enter a Ticker Symbol To Get Your Free Bull/Bear Rating & Ranking Report from "Stock Scientist" Mike Turner

Dividend Quote

LGNXZ

Ligand Pharmaceuticals Inc

Add to Scorecard

New Report from the Award-winning Analyst Who Beat the Market Over 15 Years

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.

LGNXZ:Ligand Pharmaceuticals Inc - Stock Quote and Dividend Data

LATEST CLOSE PRICE

$0.05

EXCHANGE

OTCBB

SECTOR

Health Care

LGNXZ
Ligand Pharmaceuticals Inc Dividend Information
Trailing 12 Month Dividend Yield822.43%
Projected 10 Year Dividend Yield822.43%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.44
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Dividend Payment TypeNone
Dividend Declaration DateMar. 05, 2018
Dividend Ex DateJul. 03, 2018
Dividend Record DateJun. 27, 2018
Dividend Pay DateJul. 02, 2018
Dividend Amount Current$0.109
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months1
First Dividend Paid2018

FREE INVESTOR BRIEFING

Collect an 8% Yield on this "Government Mandated Income Opportunity"

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.
LGNXZ
Ligand Pharmaceuticals Inc Stock Information
Latest Close Price$0.05
52-Week Low/High$0.00 - $0.20
Percent Held by Institutions0.00%
Revenue$287,990,000
Net Income$246,153,000
Cash Flow$27,082,000
EPS3.19%
Market Cap$0
PE Ratio0
PE Ratio to Industry66%
Debt-Equity Ratio117.00%
Debt-Equity to Industry1.38%
Total Return Last 12 Months106.08%
Total Return Last 3 Years225.60%
Total Return Last 5 Years27.19%
Latest Trade DateJan. 18, 2019
LGNXZ
Ligand Pharmaceuticals Inc Dividend Payment History
LGNXZ
Ligand Pharmaceuticals Inc Other Details

Ligand Pharmaceuticals is a biopharmaceutical company focused on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. Co. has partnerships and license agreements with pharmaceutical and biotechnology companies, and several programs under license with it is in various stages of commercialization and development. Co. has contributed research and technologies for approved medicines that treat cancer, osteoporosis, fungal infections and low blood platelets, among others. Co.'s partners have programs in clinical development targeting seizure, coma, cancer, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others.

Web Sitewww.ligand.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Try Dividend Investor PREMIUM for as low as $29

  • Dividend Allstars™ Tool
  • Proprietary Ex-dividend Calendar
  • Dividend Scorecard™ Portfolio Tracker
  • Customized Dividend Stock Screener
  • 4 FREE special reports from leading dividend experts
  • And much more...
 
Ligand Pharmaceuticals Inc Dividend Stock News and Updates

Jan. 17, 2019CLOSE PRICE DECREASE: Ligand Pharmaceuticals Inc (OTCBB: LGNXZ) on 01-17-2019 decreased close price > 10% from $0.06 to $0.05

Read more...

Jan. 12, 2019CLOSE PRICE INCREASE: Ligand Pharmaceuticals Inc (OTCBB: LGNXZ) on 01-12-2019 increased close price > 10% from $0.06 to $0.06

Read more...

Dec. 11, 2018CLOSE PRICE DECREASE: Ligand Pharmaceuticals Inc (OTCBB: LGNXZ) on 12-11-2018 decreased close price > 10% from $0.07 to $0.06

Read more...
More Ligand Pharmaceuticals Inc Dividend News
Pharmaceuticals Dividend Stock News and Updates

Jan. 19, 2019CLOSE PRICE INCREASE: Acura Pharmaceuticals Inc (OTCBB: ACUR) on 01-19-2019 increased close price > 10% from $0.13 to $0.16

Read more...

Jan. 19, 2019CLOSE PRICE INCREASE: Aradigm Corp. (OTCBB: ARDM) on 01-19-2019 increased close price > 10% from $0.55 to $0.61

Read more...

Jan. 19, 2019CLOSE PRICE INCREASE: Burzynski Research Institute Inc (OTCBB: BZYR) on 01-19-2019 increased close price > 10% from $0.03 to $0.04

Read more...
More Pharmaceuticals Dividend News
X

Search Dividend Investor